Telomerare Reverse Transcriptase (hTRT) (653-661)

Telomerase Reverse Transcriptase (hTRT) (653-661) is a synthetic peptide fragment corresponding to amino acids 653 through 661 of the human telomerase reverse transcriptase enzyme. As the catalytic subunit of telomerase, hTRT plays a central role in the maintenance of telomere length and genome stability, making it a critical factor in cellular aging, stem cell biology, and oncogenesis. The 653-661 region of hTRT has garnered research interest due to its involvement in protein-protein interactions, regulatory mechanisms, and potential post-translational modifications that influence telomerase activity. This peptide serves as a valuable biochemical tool for dissecting the structural and functional aspects of the telomerase complex in a variety of experimental contexts.

Epitope mapping: The hTRT (653-661) peptide is frequently employed in studies aimed at identifying and characterizing antibody binding sites within the telomerase reverse transcriptase protein. By providing a defined linear sequence, the peptide enables researchers to assess the specificity and affinity of monoclonal or polyclonal antibodies generated against hTRT. This application is particularly important for developing immunodetection assays, optimizing antibody-based reagents, and elucidating immune recognition mechanisms relevant to telomerase.

Protein interaction analysis: As a representative segment of the telomerase reverse transcriptase, the 653-661 peptide is utilized to investigate protein-protein interactions that regulate telomerase function. Researchers can use this peptide in pull-down assays, binding studies, or competition experiments to probe the interaction landscape of hTRT, especially for identifying regulatory partners or cofactors that modulate telomerase assembly and activity. Such studies provide insights into the molecular mechanisms underlying telomere maintenance.

Peptide-based assay development: The defined sequence of hTRT (653-661) lends itself to use as a standard or control in various in vitro assays. For example, it can serve as a calibrator or substrate in enzyme-linked immunosorbent assays (ELISA), surface plasmon resonance (SPR) measurements, or other high-throughput screening platforms designed to quantify telomerase-related activities or to screen for modulators of telomerase function. The peptide's known sequence ensures assay reproducibility and facilitates method optimization.

Post-translational modification studies: The 653-661 region of hTRT is of interest for exploring potential phosphorylation, methylation, or other post-translational modifications that may regulate telomerase activity. Synthetic peptides corresponding to this segment allow for systematic analysis of modification patterns using mass spectrometry or immunochemical techniques. These investigations help delineate the regulatory networks that control telomerase localization, stability, and enzymatic function in cellular systems.

Structural and functional analysis: Researchers utilize the hTRT (653-661) peptide as a model system for structural biology and functional studies. The peptide can be incorporated into NMR spectroscopy or crystallography experiments to resolve conformational features, or it may be used in mutagenesis studies to assess the impact of specific amino acid changes on telomerase reverse transcriptase function. These approaches contribute to a deeper understanding of the structure-function relationships within the telomerase enzyme and inform the rational design of telomerase-targeted research tools.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy